Retinoid therapy of childhood cancer. (Q34476968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Retinoid therapy of childhood cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R S Lemons

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

867-910

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Modulation of cell-surface antigens of a murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Isomerization of all-trans-retinoids to 11-cis-retinoids in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Transport and metabolism of vitamin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase II trial of 13-cis-retinoic acid in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Favorable prognostic significance of high-level retinoic acid receptor beta expression in neuroblastoma mediated by effects on cell cycle regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Tolerability of the synthetic retinoid Fenretinide (HPR)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Role of antioxidants and intracellular free radicals in retinamide-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Activation of the human MDR1 gene promoter in differentiated neuroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Cloning and chromosome mapping of human retinoid X receptor beta: selective amino acid sequence conservation of a nuclear hormone receptor in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Vitamin A and Retinoids in Health and Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Recent Advances in Chemoprevention of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic charcter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Abnormal retinal function associated with fenretinide, a synthetic retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Gamma interferon augments functional and phenotypic characteristics of vitamin D3-induced monocytoid differentiation in the U937 human leukaemic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

1 reference

7 January 2021

Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Neurite Extension and Malignancy of Neuroblastoma Cells After Treatment With Prostaglandin E 1 and Papaverine 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Improved Inhibitors of Glucosylceramide Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of advanced squamous cell carcinoma of the skin with isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Extramedullary involvement in patients with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Acute promyelocytic leukemia: a curable disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Tretinoin toxicity in children with acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

1 reference

7 January 2021

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

N-(4-hydroxyphenyl)retinamide: a Potent Inducer of Apoptosis in Human Neuroblastoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Is there a role for retinoids to treat minimal residual disease in neuroblastoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Maturing neuroblastoma and ganglioneuroblastoma: a study of four cases with long survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Involvement of Reactive Oxygen Species in N-(4-Hydroxyphenyl)retinamide-Induced Apoptosis in Cervical Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Modulation of normal myelopoiesis in vitro by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phenotypic changes of human neuroblastoma cells in culture induced by 12‐O‐tetradecanoyl‐phorbol‐13‐acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Cytotoxic effects of vitamin A in combination with vincristine, daunorubicin and 6-thioguanine upon cells from lymphoblastic leukemic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Role of cyclic amp in differentiation of human neuroblastoma cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Human neuroblastoma cell culture: effect of 5-bromodeoxyuridine on morphological differentiation and levels of neural enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Nerve growth factor induces neurite outgrowth in a clone derived from an NGF-insensitive human neuroblastoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acid confers resistance to p53-dependent apoptosis in SH-SY5Y neuroblastoma cells by modulating nuclear import of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acid in the treatment of acute promyelocytic leukemia: inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

The mechanism of retinoic acid radiosensitization is independent of AP-1 repression in a cervical carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Prognostic subgroups for undifferentiated neuroblastoma: immunohistochemical study with anti-S-100 protein antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Complete maturation of neuroblastoma with bone metastases in documented stages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

The molecular biology of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoids in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

All- trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Clonal analysis of the response of HL-60 cells to retinoic acid and vitamin D in the presence or absence of leukocyte-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Renal insufficiency after total body irradiation for pediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Synergistic effect between doxorubicin and a low dose of all-trans-retinoic acid in MCF-7 breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

All-trans-retinoic acid and pseudotumor cerebri.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differentiation of neuroblastoma cells induced by nerve growth factor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Effects of interferon-alpha, beta, and gamma on the function of differentiated leukemic HL-60 cells induced by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Differentiation therapy in acute myelogenous leukemia (non-APL).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

New agents for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970256-2

7 January 2021

10.1016/S0889-8588(05)70256-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11765378%20AND%20SRC:MED&resulttype=core&format=json